B&
Bill & Melinda Gates Foundation
Family OfficeActiveBill & Melinda Gates Foundation supports initiatives in education, world health and population, and community giving.
143
Investments
27
Exits
$75B
AUM
18.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bill & Melinda Gates Foundation.
Investment Thesis & Strategy
The Bill & Melinda Gates Foundation invests in various stages of companies and initiatives focused on education, global health, and community development, seeking to create a positive impact on the world.
Investment Activity
Deals per year over the last 6 years
1
20161
20172
20183
20192
20203
2021Portfolio Companies
Selected investments from their portfolio of 143 companies
I
Inari Agriculture
Biotech · Series C+, 2021
G
Ginkgo Bioworks
Biotech · Series C+, 2021
G
Goodpath
Healthcare · Series A, 2021
V
Vaxart
Biotech · Series B, 2020
C
CureVac
Biotech · Growth, 2020
I
Impossible Foods
Food & Beverage · Growth, 2019
P
Pivot Bio
Cleantech · Series B, 2019
P
PathAI
Healthcare · Series B, 2019
Z
Zymergen
Biotech · Seed, 2018
V
Vir Biotechnology
Biotech · Series B, 2018
K
Karius
Healthcare · Series B, 2017
A
AgBiome
Biotech · Series B, 2016
Frequently Asked Questions
Bill & Melinda Gates Foundation invests across multiple stages. Sign up to view detailed stage data.
Related Investors
Summit Capital
Seattle, United States · 13 deals
Acuitas Investments
Seattle, United States · 1 deals
Omidyar Network
Redwood City, United States · 310 deals
Webb Investment Network
San Francisco, United States · 129 deals
Hedgewood
Toronto, Canada · 115 deals
Winklevoss Capital
New York, United States · 89 deals